• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枯草杆菌蛋白酶样丝氨酸蛋白酶 (SUB1) 对于寄生虫从宿主细胞逸出至关重要。

Subtilisin-Like Serine Protease (SUB1) Is Crucial for Parasite Egress from Host Cells.

机构信息

Infectious Diseases Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.

Infectious Diseases Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

出版信息

Infect Immun. 2019 Apr 23;87(5). doi: 10.1128/IAI.00784-18. Print 2019 Mar.

DOI:10.1128/IAI.00784-18
PMID:30782859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6479043/
Abstract

Despite the severity and global burden of infection, treatments are less than optimal, and there is no effective vaccine. Egress from host cells is a key process for the completion of the life cycle of apicomplexan parasites. For species, subtilisin-like serine protease (SUB1) is a key mediator of egress. For species, calcium-dependent protein kinases (CDPKs) are critical. In this study, we characterized SUB1 expression and evaluated its effect using an infection model. We found increased expression between 12 and 20 h after infection, prior to egress. We induced silencing of SUB1 (ΔSUB1) mRNA using SUB1 single-stranded antisense RNA coupled with human Argonaute 2. Silencing of SUB1 mRNA expression did not affect parasite viability, excystation, or invasion of target cells. However, knockdown led to a 95% decrease in the proportion of released merozoites ( < 0.0001). In contrast, silencing of CDPK5 had no effect on egress. Overall, our results indicate that SUB1 is a key mediator of egress and suggest that interruption of the life cycle at this stage may effectively inhibit the propagation of infection.

摘要

尽管 感染的严重性和全球负担很大,但治疗方法并不理想,也没有有效的疫苗。从宿主细胞逸出是完成顶复门寄生虫生命周期的关键过程。对于 物种,枯草杆菌蛋白酶样丝氨酸蛋白酶 (SUB1) 是逸出的关键介质。对于 物种,钙依赖性蛋白激酶 (CDPK) 是关键。在这项研究中,我们对 SUB1 的表达进行了表征,并使用感染模型评估了其作用。我们发现,在 感染后 12 至 20 小时之间,SUB1 的表达增加,在逸出之前。我们使用 SUB1 单链反义 RNA 与人 Argonaute 2 偶联来诱导 SUB1 (ΔSUB1) mRNA 的沉默。SUB1 mRNA 表达的沉默不影响寄生虫的活力、出囊或靶细胞的入侵。然而,敲低导致释放的裂殖子比例降低了 95%(<0.0001)。相比之下,CDPK5 的沉默对逸出没有影响。总体而言,我们的结果表明 SUB1 是 逸出的关键介质,并表明在此阶段中断生命周期可能有效抑制感染的传播。

相似文献

1
Subtilisin-Like Serine Protease (SUB1) Is Crucial for Parasite Egress from Host Cells.枯草杆菌蛋白酶样丝氨酸蛋白酶 (SUB1) 对于寄生虫从宿主细胞逸出至关重要。
Infect Immun. 2019 Apr 23;87(5). doi: 10.1128/IAI.00784-18. Print 2019 Mar.
2
Cryptosporidium parvum cyclic GMP-dependent protein kinase (PKG): An essential mediator of merozoite egress.微小隐孢子虫环鸟苷酸依赖蛋白激酶(PKG):裂殖子外逸的必需介质。
Mol Biochem Parasitol. 2020 May;237:111277. doi: 10.1016/j.molbiopara.2020.111277. Epub 2020 Apr 26.
3
Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro.类枯草杆菌蛋白酶CpSUB1在微小隐孢子虫体外感染中的作用
Eukaryot Cell. 2009 Apr;8(4):470-7. doi: 10.1128/EC.00306-08. Epub 2009 Jan 23.
4
Prodomain-driven enzyme dimerization: a pH-dependent autoinhibition mechanism that controls Sub1 activity before merozoite egress.结构域驱动的酶二聚化:一种pH依赖的自我抑制机制,在裂殖子逸出前控制Sub1活性。
mBio. 2024 Mar 13;15(3):e0019824. doi: 10.1128/mbio.00198-24. Epub 2024 Feb 22.
5
A key role for Plasmodium subtilisin-like SUB1 protease in egress of malaria parasites from host hepatocytes.疟原虫亚碱性 SUB1 蛋白酶在疟原虫从宿主肝细胞中逸出中的关键作用。
J Biol Chem. 2013 Nov 15;288(46):33336-46. doi: 10.1074/jbc.M113.513234. Epub 2013 Oct 2.
6
Activation of the Egress Effector Subtilisin-Like Protease 1 Is Mediated by Plasmepsin X Destruction of the Prodomain.出芽效应子枯草溶菌素样蛋白酶 1 的激活是由质膜蛋白酶 X 破坏前导序列介导的。
mBio. 2023 Apr 25;14(2):e0067323. doi: 10.1128/mbio.00673-23. Epub 2023 Apr 10.
7
Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.利用基于扫描电子显微镜的免疫金标技术标记表面表位以鉴定隐孢子虫生活阶段。
Mol Cell Probes. 2012 Feb;26(1):21-8. doi: 10.1016/j.mcp.2011.11.001. Epub 2011 Nov 11.
8
Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.疟原虫枯草溶菌素样蛋白酶 1(SUB1):对泛疟疾药物靶点的活性位点结构、特异性和功能的深入了解。
Int J Parasitol. 2012 May 15;42(6):597-612. doi: 10.1016/j.ijpara.2012.04.005. Epub 2012 Apr 27.
9
Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.枯草杆菌蛋白酶样丝氨酸蛋白酶 1(SUB1)作为新兴的抗疟药物靶点:抑制剂发现的最新进展。
J Med Chem. 2022 Oct 13;65(19):12535-12545. doi: 10.1021/acs.jmedchem.2c01093. Epub 2022 Sep 22.
10
A malaria parasite subtilisin propeptide-like protein is a potent inhibitor of the egress protease SUB1.疟原虫枯草杆菌蛋白酶原肽样蛋白是一种有效的出芽蛋白酶 SUB1 的抑制剂。
Biochem J. 2020 Jan 31;477(2):525-540. doi: 10.1042/BCJ20190918.

引用本文的文献

1
Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions.隐孢子虫的分子发病机制及治疗干预进展。
Parasite. 2025;32:7. doi: 10.1051/parasite/2025001. Epub 2025 Feb 4.
2
Dense granule protein 41 of Neospora caninum modulates tachyzoite egress by regulating microneme secretion.刚地弓形虫致密颗粒蛋白 41 调节微线体分泌从而调控速殖子出芽。
Parasitol Res. 2024 Nov 18;123(11):386. doi: 10.1007/s00436-024-08405-9.
3
Targeting the proteome and organelles for potential antimalarial drug candidates.针对蛋白质组和细胞器寻找潜在的抗疟药物候选物。
Heliyon. 2022 Aug;8(8):e10390. doi: 10.1016/j.heliyon.2022.e10390. Epub 2022 Aug 24.
4
RNA-Based Therapy for Cryptosporidium parvum Infection: Proof-of-Concept Studies.基于 RNA 的隐孢子虫感染治疗:概念验证研究。
Infect Immun. 2022 Jul 21;90(7):e0019622. doi: 10.1128/iai.00196-22. Epub 2022 Jun 1.
5
Cryptosporidium parvum cyclic GMP-dependent protein kinase (PKG): An essential mediator of merozoite egress.微小隐孢子虫环鸟苷酸依赖蛋白激酶(PKG):裂殖子外逸的必需介质。
Mol Biochem Parasitol. 2020 May;237:111277. doi: 10.1016/j.molbiopara.2020.111277. Epub 2020 Apr 26.
6
Systematic gene silencing identified Cryptosporidium nucleoside diphosphate kinase and other molecules as targets for suppression of parasite proliferation in human intestinal cells.系统基因沉默鉴定出隐孢子虫核苷二磷酸激酶和其他分子可作为抑制人肠道细胞寄生虫增殖的靶标。
Sci Rep. 2019 Aug 21;9(1):12153. doi: 10.1038/s41598-019-48544-z.

本文引用的文献

1
Evolution of mitosome metabolism and invasion-related proteins in Cryptosporidium.隐孢子虫中线粒体代谢与侵袭相关蛋白的进化
BMC Genomics. 2016 Dec 8;17(1):1006. doi: 10.1186/s12864-016-3343-5.
2
Protein Malnutrition Impairs Intestinal Epithelial Cell Turnover, a Potential Mechanism of Increased Cryptosporidiosis in a Murine Model.蛋白质营养不良会损害肠道上皮细胞更新,这是小鼠模型中隐孢子虫病增加的一种潜在机制。
Infect Immun. 2016 Nov 18;84(12):3542-3549. doi: 10.1128/IAI.00705-16. Print 2016 Dec.
3
The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).利用全球肠道多中心研究(GEMS)的数据,评估撒哈拉以南非洲和南亚中/高死亡率地区24个月以下儿童隐孢子虫腹泻病负担
PLoS Negl Trop Dis. 2016 May 24;10(5):e0004729. doi: 10.1371/journal.pntd.0004729. eCollection 2016 May.
4
Natural History of Cryptosporidiosis in a Longitudinal Study of Slum-Dwelling Bangladeshi Children: Association with Severe Malnutrition.一项针对居住在贫民窟的孟加拉国儿童的纵向研究中隐孢子虫病的自然史:与重度营养不良的关联。
PLoS Negl Trop Dis. 2016 May 4;10(5):e0004564. doi: 10.1371/journal.pntd.0004564. eCollection 2016 May.
5
Preassembled Single-Stranded RNA-Argonaute Complexes: A Novel Method to Silence Genes in Cryptosporidium.预组装的单链RNA-AGO蛋白复合物:一种沉默隐孢子虫基因的新方法。
J Infect Dis. 2016 Apr 15;213(8):1307-14. doi: 10.1093/infdis/jiv588. Epub 2015 Dec 11.
6
Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward.隐孢子虫的治疗:我们所知道的、存在的差距以及未来的方向。
Curr Trop Med Rep. 2015 Sep;2(3):181-187. doi: 10.1007/s40475-015-0056-9. Epub 2015 Aug 1.
7
Identification of invasion proteins of Cryptosporidium parvum.微小隐孢子虫侵袭蛋白的鉴定
World J Microbiol Biotechnol. 2015 Dec;31(12):1923-34. doi: 10.1007/s11274-015-1936-9.
8
The calcium signaling toolkit of the Apicomplexan parasites Toxoplasma gondii and Plasmodium spp.顶复门寄生虫刚地弓形虫和疟原虫属的钙信号传导工具包
Cell Calcium. 2015 Mar;57(3):186-93. doi: 10.1016/j.ceca.2014.12.010. Epub 2014 Dec 31.
9
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.隐孢子虫的全球负担、新型诊断方法、治疗方法及疫苗靶点综述
Lancet Infect Dis. 2015 Jan;15(1):85-94. doi: 10.1016/S1473-3099(14)70772-8. Epub 2014 Sep 29.
10
CDPKs of Cryptosporidium parvum--stage-specific expression in vitro.微小隐孢子虫钙依赖蛋白激酶的体外阶段特异性表达。
Parasitol Res. 2014 Jul;113(7):2525-33. doi: 10.1007/s00436-014-3902-0. Epub 2014 May 9.